Home / Resource Library / DOUBLE REFRACTORY STATUS CONFIRMS INFERIOR SURVIVAL IN LARGE B-CELL LYMPHOMA ELIGIBLE FOR THIRD-LINE CD19 CHIMERIC ANTIGEN T-CELL THERAPY
DOUBLE REFRACTORY STATUS CONFIRMS INFERIOR SURVIVAL IN LARGE B-CELL LYMPHOMA ELIGIBLE FOR THIRD-LINE CD19 CHIMERIC ANTIGEN T-CELL THERAPY